Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Journal of Thrombosis and Haemostasis : JTH|November 9, 2023
Plasma from patients with vaccine-induced immune thrombotic thrombocytopenia displays increased fibrinolytic potential and enhances tissue-type plasminogen activator but not urokinase-mediated plasminogen activationCharithani B Keragala, James D McFadyen, Heidi Ho, et al.
Pharmacotherapy|December 25, 2010
Measuring diabetes care in the national interdisciplinary primary care practice-based research network (NIPC-PBRN)Lori M Dickerson, Adrienne Z Ables, Charles J Everett, et al.
Journal of Immunological Methods|March 31, 1998
A sensitive ELISPOT assay to detect low-frequency human T lymphocytesM McCutcheon, N Wehner, A Wensky, et al.
ACS Sensors|February 5, 2024
A Coumarin-Based Array for the Discrimination of AmyloidsNatalie Trinh, Kaustubh R Bhuskute, Nikhil R Varghese, et al.
Mabs|February 5, 2014
Multiplexed screening of natural humoral immunity identifies antibodies at fine specificity for complex and dynamic viral targetsKrista M McCutcheon, Julia Gray, Natalie Y Chen, et al.
Blood Advances|July 24, 2026
Tenecteplase (TNK) and other TNK formulations lose PAI-1 resistance in their two-chain form: Comparison with alteplaseZikou Liu, Isabel Tippett, Fiona M McCutcheon, et al.
Nature Genetics|August 31, 2001
Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1K Grohmann, M Schuelke, A Diers, et al.
Elife|December 11, 2019
Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomicsNatasha D Durham, Aditi Agrawal, Eric Waltari, et al.
Pharmacy (Basel, Switzerland)|December 22, 2019
A Quantitative and Narrative Evaluation of Goodman and Gilman's Pharmacological Basis of TherapeuticsBrian J Piper, Alexandria A Alinea, John R Wroblewski, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 13, 2026
Development of a Diagnostic Autoantibody Assay to a Consensus Motif for the Risk Prediction of Epstein-Barr Virus-Related Multiple SclerosisKrista M McCutcheon, Aaron Bodansky, Thomas T Ngo, et al.
Pageof 7